• version
• test
• safety
• ONCOLOGY
• e-iatrogenesis

Medicinal treatment of cancer is critical for patient safety. In fact, anticancer drugs present a narrow therapeutic index with potentially lethal adverse events. Many studies have highlighted the benefit of computerised prescription (CP) in oncology.1 ,2 However, CP may lead to the emergence of new errors defined as e-iatrogenesis that can result in unintended consequences.3 Unfortunately, prescribing software errors are more common than they should be, especially in a high-risk field such as oncology. Such errors, and their putative patient consequences, may occur following software version upgrading. Thus, even if software publishers routinely realise regression tests for …